Assessment of Dutasteride Topical Solution in Male Androgenetic Alopecia

This is a randomized, open-label phase 1/2a study designed to evaluate the pharmacokinetics, pharmacodynamics, and safety of AD-303A (topical formulation) and AD-3031 in male patients with androgenetic alopecia. The study aims to compare pharmacological characteristics and safety profiles to support dose selection for further clinical development.

NCT Number	NCT07490327
Lead Sponsor	Moogene Medi Co., Ltd Collaborators: Seoul National University Hospital
Conditions	Androgenetic Alopecia
Enrollment	30 participants
Start Date	2026-04
Primary Completion	2026-09 (estimated)
Study Completion	2026-12 (estimated)
Updated on ClinicalTrials.gov	2026-03-24